David J Yvars Group Acquires Shares of 3,770 Astera Labs, Inc. (NASDAQ:ALAB)

David J Yvars Group bought a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,770 shares of the company’s stock, valued at approximately $499,000.

A number of other hedge funds also recently made changes to their positions in ALAB. Hollencrest Capital Management bought a new stake in Astera Labs in the 3rd quarter worth approximately $26,000. ORG Wealth Partners LLC purchased a new position in shares of Astera Labs in the fourth quarter valued at $42,000. US Bancorp DE bought a new stake in Astera Labs in the third quarter worth $46,000. First Horizon Advisors Inc. purchased a new stake in Astera Labs during the third quarter valued at $49,000. Finally, Allworth Financial LP raised its stake in Astera Labs by 445.5% during the third quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock valued at $57,000 after purchasing an additional 891 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ALAB has been the topic of a number of research reports. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and boosted their target price for the stock from $100.00 to $120.00 in a report on Thursday, January 2nd. Craig Hallum raised their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Stifel Nicolaus lifted their target price on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $105.75.

Get Our Latest Stock Report on ALAB

Insiders Place Their Bets

In other news, Director Stefan A. Dyckerhoff sold 50,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $89.70, for a total transaction of $4,485,000.00. Following the sale, the director now directly owns 129,617 shares of the company’s stock, valued at $11,626,644.90. This represents a 27.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Sanjay Gajendra sold 740,000 shares of Astera Labs stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $96.59, for a total value of $71,476,600.00. Following the completion of the transaction, the insider now owns 775,000 shares of the company’s stock, valued at approximately $74,857,250. This represents a 48.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,690,452 shares of company stock worth $167,581,256.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $127.19 on Tuesday. The firm has a fifty day moving average price of $116.88 and a 200 day moving average price of $74.77. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The business had revenue of $113.10 million during the quarter, compared to analyst estimates of $97.50 million. The company’s revenue was up 47.1% compared to the same quarter last year. As a group, equities analysts expect that Astera Labs, Inc. will post -0.45 EPS for the current year.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.